Dr. Fareha Malik's path to specializing in treatment-resistant depression is deeply personal. As the founder of Advanced Psychiatry of Elgin, her passion for psychiatry is rooted in a profound desire to help others. However, it wasn't until she witnessed her own family member struggle with severe depression that she changed the trajectory of her career.

"Watching a loved one suffer was the most challenging experience of my life," Dr. Malik reflects. "I realized that for many, traditional treatment options simply aren't enough." Dr. Malik began to specialize in innovative, interventional treatments like ketamine and the FDA approved Spravato (esketamine), both of which offer hope for patients with medication-resistant depression. These treatments differ from traditional antidepressants as they target the brain's glutamate system rather than the serotonin or norepinephrine systems. While antidepressants can take weeks to take effect, ketamine and Spravato provide instant relief.

Ketamine, administered in carefully controlled doses, works quickly by stimulating glutamate receptors in the brain, which helps to rewire neural circuits involved in mood regulation. Similarly, Spravato, delivered as a nasal spray, works on the same glutamate system and provides rapid relief. Both treatments harness the brain's own ability to heal and adapt.

At Advanced Psychiatry of Elgin, patients receive ketamine and Spravato under the supervision of trained professionals in a safe and comfortable environment. Dr. Malik and her team offer empathy, compassion, and a commitment to their patients' healing journeys.

If you are ready to explore alternative treatments for major depression and take the first step toward reclaiming your life, contact Advanced Psychiatry of Elgin to learn more about these breakthrough therapies.

847-783-0307